Compounds > n,n-bis(trimethylsilyl)-2,2,2-trifluoroacetamide
Page last updated: 2024-08-24

n,n-bis(trimethylsilyl)-2,2,2-trifluoroacetamide and Parkinson Disease

n,n-bis(trimethylsilyl)-2,2,2-trifluoroacetamide has been researched along with Parkinson Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hashizume, Y; Kaneda, N; Nagatsu, T; Niwa, T; Sasaoka, T; Takeda, N; Tatematsu, A; Yoshizumi, H1

Other Studies

1 other study(ies) available for n,n-bis(trimethylsilyl)-2,2,2-trifluoroacetamide and Parkinson Disease

ArticleYear
Detection of tetrahydroisoquinoline in parkinsonian brain as an endogenous amine by use of gas chromatography-mass spectrometry.
    Journal of chromatography, 1989, Jul-21, Volume: 491, Issue:2

    Topics: Aged; Brain Chemistry; Female; Gas Chromatography-Mass Spectrometry; Humans; Isoquinolines; Parkinson Disease; Phenethylamines; Tetrahydroisoquinolines; Trimethylsilyl Compounds

1989